Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Data as of Jan 30
 -0.13 / -1.36%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. It applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack Pharmaceuticals was founded by Anthony J. Sinskey, Gavin MacBeath and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Contact Information

Merrimack Pharmaceuticals, Inc.
One Kendall Square
Cambridge Massachusetts 02139
P:(617) 441-1000
Investor Relations:
(617) 441-7602



Individual stakeholders8.36%
Mutual fund holders33.11%
Other institutional19.68%

Top Executives

Robert J. MulroyPresident, Chief Executive Officer & Director
William M. McClementsSenior Vice President-Operations
William A. SullivanChief Financial Officer & Treasurer
Edward J. StewartSenior Vice President
Jeffrey A. MunsieVice President & General Counsel

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.